BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33548740)

  • 21. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.
    Liu Z; Wu M; Shi H; Huang C; Luo S; Song X
    J Cell Biochem; 2019 Jun; 120(6):10228-10238. PubMed ID: 30582201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas.
    Gopalan V; Ebrahimi F; Islam F; Vider J; Qallandar OB; Pillai S; Lu CT; Lam AK
    Exp Cell Res; 2018 Sep; 370(2):245-253. PubMed ID: 29958837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.
    Deng ZM; Chen GH; Dai FF; Liu SY; Yang DY; Bao AY; Cheng YX
    PLoS One; 2022; 17(4):e0267108. PubMed ID: 35486636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide analysis of aberrant gene expression and methylation profiles reveals susceptibility genes and underlying mechanism of cervical cancer.
    Lin H; Ma Y; Wei Y; Shang H
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():147-152. PubMed ID: 27863272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2.
    Liang HX; Li YH
    Genes Genomics; 2020 Apr; 42(4):371-382. PubMed ID: 31902110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.
    Yu Y; Shen HM; Fang DM; Meng QJ; Xin YH
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4812-4819. PubMed ID: 30070314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
    Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
    Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
    Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
    Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
    Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
    Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
    FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
    Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
    Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
    Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
    Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.
    Shinden Y; Akiyoshi S; Ueo H; Nambara S; Saito T; Komatsu H; Ueda M; Hirata H; Sakimura S; Uchi R; Takano Y; Iguchi T; Eguchi H; Sugimachi K; Kijima Y; Ueo H; Natsugoe S; Mimori K
    Anticancer Res; 2015 Jan; 35(1):123-7. PubMed ID: 25550542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.